He Transitioned, Regretted It, and Faced the Truth About Autogynephilia - Ray (#9)
17 April 2025
With Ray
Global
Ray spent eight years living as a transwoman before detransitioning. His account addresses autogynephilia—a concept backed by decades of research but sidelined in contemporary gender clinics—and raises questions about the sequencing of dysphoria, the influence of online communities, and the health consequences of prolonged hormone use. His story illustrates why evidence-based psychological assessment should precede medical intervention, a conclusion now endorsed by multiple European systematic reviews.
Ray offers a candid first-person account of a pattern beginning in childhood: an attraction to women's clothing with an erotic charge, managed for years through shame and secrecy. That pattern—autogynephilic in character—eventually drew him toward a transgender identity. He traces the stages with unusual clarity, including the triggers that accelerated each shift, from exposure to high-profile public transitions to immersion in online communities that reinforced and normalised his emerging sense of self. Autogynephilia was defined by sexologist Ray Blanchard in the late 1980s as a male person's propensity to be sexually aroused by the thought of himself as a woman. Blanchard's two-type taxonomy was once a standard clinical category; it has since been largely removed from guidelines under sustained pressure from trans advocacy groups. Ray's account raises the question of whether that erasure has left clinicians without adequate tools to assess a common presentation accurately—and whether the absence of this diagnostic framework contributes to misdiagnosis and later regret. One of the most clinically significant points in Ray's account is the timing of his body dysphoria: it emerged after he began identifying as transgender, not before. This sequence has been noted in qualitative research on detransitioners and matters because the affirmation model assumes pre-existing, stable dysphoria that medicalisation resolves. When dysphoria is instead partly generated by the process of social identification and online immersion, the clinical case for rapid hormonal intervention weakens considerably. The UK's Cass Review flagged precisely this dynamic in 2024, noting that peer and digital environments can shape gender-related presentations in ways that are difficult to disentangle from underlying psychological need. After eight years of hormone use, Ray experienced health problems that contributed to his decision to detransition. The long-term physiological effects of cross-sex hormones in males—including cardiovascular risk, bone-density changes, and potentially irreversible effects on fertility and sexual function—are documented in the medical literature, yet detransitioner accounts consistently describe inadequate informed consent at gender clinics. His experience aligns with findings from detransitioner surveys that cite health concerns as a primary driver of decisions to discontinue hormonal treatment. Ray's testimony is not a denial of gender dysphoria or of the people who experience it. It is a case for accurate differential diagnosis, for honest clinical engagement with autogynephilia as a real and researched phenomenon, and for the primacy of psychotherapy before irreversible medical steps are taken. That case is increasingly supported by the direction of European clinical policy: Sweden, Finland, and Norway have all restricted routine youth transition on evidentiary grounds, and the NICE evidence reviews found the quality of research supporting hormonal intervention in minors to be very low. Personal accounts like Ray's give human texture to conclusions the evidence base is already reaching.
